{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:47:50Z","timestamp":1782100070144,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-025-04967-2","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T04:59:56Z","timestamp":1769489996000},"page":"9871-9879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk insights for clinical medication: a Mendelian randomization study of 23 drugs and lung cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Huachuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"4967_CR1","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s10067-018-4152-9","volume":"37","author":"SC Bae","year":"2018","unstructured":"Bae SC, Lee YH (2018) Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: a Mendelian randomization. Clin Rheumatol 37:2415\u20132421. https:\/\/doi.org\/10.1007\/s10067-018-4152-9","journal-title":"Clin Rheumatol"},{"key":"4967_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/HJH.0000000000002379","volume":"38","author":"A Battistoni","year":"2020","unstructured":"Battistoni A, Tocci G, Coluccia R, Burnier M, Ruilope LM, Volpe M (2020) Antihypertensive drugs and the risk of cancer: a critical review of available evidence and perspective. J Hypertens 38:1005\u20131015. https:\/\/doi.org\/10.1097\/HJH.0000000000002379","journal-title":"J Hypertens"},{"key":"4967_CR3","doi-asserted-by":"publisher","unstructured":"Bittoni M, Carbone D, Harris R (2017) Chronic inflammation, NSAIDS and the risk of lung cancer death. J Thorac Oncol 12:S257. https:\/\/doi.org\/10.1016\/j.jtho.2016.11.247","DOI":"10.1016\/j.jtho.2016.11.247"},{"key":"4967_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016a) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40:304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"key":"4967_CR5","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016b) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45:1961\u20131974. https:\/\/doi.org\/10.1093\/ije\/dyw220","journal-title":"Int J Epidemiol"},{"key":"4967_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"4967_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"key":"4967_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molimm.2017.06.018","volume":"90","author":"D Che","year":"2017","unstructured":"Che D, Zhang S, Jing Z, Shang L, Jin S, Liu F, Shen J, Li Y, Hu J, Meng Q, Yu Y (2017) Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2\/PGE(2)\/beta-catenin signalling pathway. Mol Immunol 90:197\u2013210. https:\/\/doi.org\/10.1016\/j.molimm.2017.06.018","journal-title":"Mol Immunol"},{"key":"4967_CR9","doi-asserted-by":"publisher","unstructured":"Chen S, McMiller T, Sankaran P, Kampta K, Topalian S (2021) 288 The COX-2 pathway as a mediator of resistance to anti-PD-1 therapy. J Immunother Cancer 9(Suppl 2). https:\/\/doi.org\/10.1136\/jitc-2021-SITC2021.288","DOI":"10.1136\/jitc-2021-SITC2021.288"},{"key":"4967_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/aje\/kwm165","volume":"166","author":"Z Fewell","year":"2007","unstructured":"Fewell Z, Davey Smith G, Sterne JA (2007) The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol 166:646\u2013655. https:\/\/doi.org\/10.1093\/aje\/kwm165","journal-title":"Am J Epidemiol"},{"key":"4967_CR11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pineros M, Znaor A, Parkin DM, Soerjomataram I, Bray F (2025) The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer 156:1336\u20131346. https:\/\/doi.org\/10.1002\/ijc.35278","journal-title":"Int J Cancer"},{"key":"4967_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1392745","volume":"15","author":"S Gao","year":"2024","unstructured":"Gao S, Wei G, Ma Q, Wang X, Wang S, Niu Y (2024) Causal relationship between anti-inflammatory drugs and cancer: a pan-cancer study with Mendelian randomization. Front Genet 15:1392745. https:\/\/doi.org\/10.3389\/fgene.2024.1392745","journal-title":"Front Genet"},{"key":"4967_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72198-1","volume":"14","author":"F Gu","year":"2024","unstructured":"Gu F, Zhou Y, Tian L, Chen J, Zhang C, Huang Z, Yu W, Xie K (2024) Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K\/AKT\/mTOR pathway. Sci Rep 14:21130. https:\/\/doi.org\/10.1038\/s41598-024-72198-1","journal-title":"Sci Rep"},{"key":"4967_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/1573406417666210809162636","volume":"18","author":"PA Halim","year":"2022","unstructured":"Halim PA, El-Nassan HB, El-Dash YS (2022) Design and synthesis of novel ibuprofen derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents: evaluation of PGE2, TNF-alpha, IL-6 and histopathological study. Med Chem 18:427\u2013443. https:\/\/doi.org\/10.2174\/1573406417666210809162636","journal-title":"Med Chem"},{"key":"4967_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/JTO.0000000000000180","volume":"9","author":"P Hatlen","year":"2014","unstructured":"Hatlen P, Langhammer A, Carlsen SM, Salvesen O, Amundsen T (2014) Self-reported cardiovascular disease and the risk of lung cancer, the HUNT study. J Thorac Oncol 9:940\u2013946. https:\/\/doi.org\/10.1097\/JTO.0000000000000180","journal-title":"J Thorac Oncol"},{"key":"4967_CR16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife. https:\/\/doi.org\/10.7554\/eLife.34408","journal-title":"Elife"},{"key":"4967_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/CEJ.0000000000000176","volume":"25","author":"F Hochmuth","year":"2016","unstructured":"Hochmuth F, Jochem M, Schlattmann P (2016) Meta-analysis of aspirin use and risk of lung cancer shows notable results. Eur J Cancer Prev 25:259\u2013268. https:\/\/doi.org\/10.1097\/CEJ.0000000000000176","journal-title":"Eur J Cancer Prev"},{"key":"4967_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.784922","volume":"12","author":"S Huang","year":"2021","unstructured":"Huang S, Tian F, Yang X, Fang S, Fan Y, Bao J (2021) Physical activity and systemic lupus erythematosus among European populations: a two-sample Mendelian randomization study. Front Genet 12:784922. https:\/\/doi.org\/10.3389\/fgene.2021.784922","journal-title":"Front Genet"},{"key":"4967_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00432-020-03394-5","volume":"147","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Su Z, Li C, Wang R, Wen Y, Liang H, He J, Liang W (2021) Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses. J Cancer Res Clin Oncol 147:139\u2013151. https:\/\/doi.org\/10.1007\/s00432-020-03394-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"4967_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/ajh\/hpac066","volume":"35","author":"S Kidoguchi","year":"2022","unstructured":"Kidoguchi S, Sugano N, Yokoo T, Kaneko H, Akazawa H, Mukai M, Node K, Yano Y, Nishiyama A (2022) Antihypertensive drugs and cancer risk. Am J Hypertens 35:767\u2013783. https:\/\/doi.org\/10.1093\/ajh\/hpac066","journal-title":"Am J Hypertens"},{"key":"4967_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-023-00742-8","volume":"18","author":"LY Kong","year":"2023","unstructured":"Kong LY, Chen XY, Lu X, Caiyin Q, Yang DH (2023) Association of lung-intestinal microecology and lung cancer therapy. Chin Med 18:37. https:\/\/doi.org\/10.1186\/s13020-023-00742-8","journal-title":"Chin Med"},{"key":"4967_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1530\/ERC-18-0353","volume":"26","author":"S Latteyer","year":"2019","unstructured":"Latteyer S, Christoph S, Theurer S, Hones GS, Schmid KW, Fuhrer D, Moeller LC (2019) Thyroxine promotes lung cancer growth in an orthotopic mouse model. Endocr Relat Cancer 26:565\u2013574. https:\/\/doi.org\/10.1530\/ERC-18-0353","journal-title":"Endocr Relat Cancer"},{"key":"4967_CR23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40263-018-0564-y","volume":"32","author":"C Lebrun","year":"2018","unstructured":"Lebrun C, Rocher F (2018) Cancer risk in patients with multiple sclerosis: potential impact of disease-modifying drugs. CNS Drugs 32:939\u2013949. https:\/\/doi.org\/10.1007\/s40263-018-0564-y","journal-title":"CNS Drugs"},{"key":"4967_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08971-6","volume":"21","author":"J Li","year":"2021","unstructured":"Li J, Lam ASM, Yau STY, Yiu KKL, Tsoi KKF (2021) Antihypertensive treatments and risks of lung cancer: a large population-based cohort study in Hong Kong. BMC Cancer 21:1202. https:\/\/doi.org\/10.1186\/s12885-021-08971-6","journal-title":"BMC Cancer"},{"key":"4967_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02334-8","volume":"21","author":"X Liu","year":"2021","unstructured":"Liu X, Yang J, Yang C, Huang X, Han M, Kang F, Li J (2021) Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR\/Src\/mTOR pathway. Cancer Cell Int 21:622. https:\/\/doi.org\/10.1186\/s12935-021-02334-8","journal-title":"Cancer Cell Int"},{"key":"4967_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1160993","volume":"13","author":"S Luo","year":"2023","unstructured":"Luo S, Li W, Li Q, Zhang M, Wang X, Wu S, Li Y (2023) Causal effects of gut microbiota on the risk of periodontitis: a two-sample Mendelian randomization study. Front Cell Infect Microbiol 13:1160993. https:\/\/doi.org\/10.3389\/fcimb.2023.1160993","journal-title":"Front Cell Infect Microbiol"},{"key":"4967_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2196088","volume":"55","author":"Z Ma","year":"2023","unstructured":"Ma Z, Song P, Ji D, Zheng M, Qiu G, Liu Z, Wang B (2023) Thyroid hormones as biomarkers of lung cancer: a retrospective study. Ann Med 55:2196088. https:\/\/doi.org\/10.1080\/07853890.2023.2196088","journal-title":"Ann Med"},{"key":"4967_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","volume":"48","author":"J Malhotra","year":"2016","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P (2016) Risk factors for lung cancer worldwide. Eur Respir J 48:889\u2013902. https:\/\/doi.org\/10.1183\/13993003.00359-2016","journal-title":"Eur Respir J"},{"key":"4967_CR29","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/ng.3892","volume":"49","author":"JD McKay","year":"2017","unstructured":"McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeboller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Shen H, Hong YC, Yuan JM, Bertazzi PA, Pesatori AC, Ye Y, Diao N, Su L, Zhang R, Brhane Y, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman CA, Wilkens LR, Fernandez-Somoano A, Fernandez-Tardon G, van der Heijden HFM, Kim JH, Dai J, Hu Z, Davies MPA, Marcus MW, Brunnstrom H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Doherty JA, Barnett MP, Chen C, Goodman GE, Cox A, Taylor F, Woll P, Bruske I, Wichmann HE, Manz J, Muley TR, Risch A, Rosenberger A, Grankvist K, Johansson M, Shepherd FA, Tsao MS, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Koh WP, Gao YT, Houlston RS, McLaughlin J, Stevens VL, Joubert P, Lamontagne M, Nickle DC, Obeidat M, Timens W, Zhu B, Song L, Kachuri L, Artigas MS, Tobin MD, Wain LV, SpiroMeta C, Rafnar T, Thorgeirsson TE, Reginsson GW, Stefansson K, Hancock DB, Bierut LJ, Spitz MR, Gaddis NC, Lutz SM, Gu F, Johnson EO, Kamal A, Pikielny C, Zhu D, Lindstroem S, Jiang X, Tyndale RF, Chenevix-Trench G, Beesley J, Bosse Y, Chanock S, Brennan P, Landi MT, Amos CI (2017) Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet 49:1126\u20131132. https:\/\/doi.org\/10.1038\/ng.3892","journal-title":"Nat Genet"},{"key":"4967_CR30","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/annonc\/mdq779","volume":"22","author":"SW Oh","year":"2011","unstructured":"Oh SW, Myung SK, Park JY, Lee CM, Kwon HT (2011) Aspirin use and risk for lung cancer: a meta-analysis. Ann Oncol 22:2456\u20132465. https:\/\/doi.org\/10.1093\/annonc\/mdq779","journal-title":"Ann Oncol"},{"key":"4967_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120374","volume":"294","author":"B Patel","year":"2022","unstructured":"Patel B, Priefer R (2022) Impact of chronic obstructive pulmonary disease, lung infection, and\/or inhaled corticosteroids use on potential risk of lung cancer. Life Sci 294:120374. https:\/\/doi.org\/10.1016\/j.lfs.2022.120374","journal-title":"Life Sci"},{"key":"4967_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/aje\/kwt084","volume":"178","author":"BL Pierce","year":"2013","unstructured":"Pierce BL, Burgess S (2013) Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 178:1177\u20131184. https:\/\/doi.org\/10.1093\/aje\/kwt084","journal-title":"Am J Epidemiol"},{"key":"4967_CR33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","volume":"17","author":"F Pucci","year":"2016","unstructured":"Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, Pfirschke C, Engblom C, Mino-Kenudson M, Hynes RO, Weissleder R, Pittet MJ (2016) PF4 promotes platelet production and lung cancer growth. Cell Rep 17:1764\u20131772. https:\/\/doi.org\/10.1016\/j.celrep.2016.10.031","journal-title":"Cell Rep"},{"key":"4967_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bmj.1.6107.210","volume":"1","author":"JG Ratcliffe","year":"1978","unstructured":"Ratcliffe JG, Stack BH, Burt RW, Radcliffe WA, Spilg WG, Cuthbert J, Kennedy RS (1978) Thyroid function in lung cancer. Br Med J 1:210\u2013212. https:\/\/doi.org\/10.1136\/bmj.1.6107.210","journal-title":"Br Med J"},{"key":"4967_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafo MR, Palmer T, Schooling CM, Wallace C, Zhao Q, Smith GD (2022) Mendelian randomization. Nat Rev Methods Primers. https:\/\/doi.org\/10.1038\/s43586-021-00092-5","journal-title":"Nat Rev Methods Primers"},{"key":"4967_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918749","volume":"13","author":"N Sang","year":"2022","unstructured":"Sang N, Gao RC, Zhang MY, Wu ZZ, Wu ZG, Wu GC (2022) Causal relationship between sleep traits and risk of systemic lupus erythematosus: a two-sample mendelian randomization study. Front Immunol 13:918749. https:\/\/doi.org\/10.3389\/fimmu.2022.918749","journal-title":"Front Immunol"},{"key":"4967_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193275","author":"ER Sauter","year":"2024","unstructured":"Sauter ER, Agurs-Collins T (2024) Mechanisms by which pharmacotherapy may impact cancer risk among individuals with overweight and obesity. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16193275","journal-title":"Cancers (Basel)"},{"key":"4967_CR38","doi-asserted-by":"publisher","unstructured":"Sidorova M, Petrikaite V (2022) The effect of beta adrenoreceptor blockers on viability and cell colony formation of non-small cell lung cancer cell lines A549 and H1299. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27061938","DOI":"10.3390\/molecules27061938"},{"key":"4967_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1158\/1055-9965.EPI-20-1028","volume":"30","author":"NC Stoer","year":"2021","unstructured":"Stoer NC, Botteri E, Thoresen GH, Karlstad O, Weiderpass E, Friis S, Pottegard A, Andreassen BK (2021) Drug use and cancer risk: a drug-wide association study (DWAS) in Norway. Cancer Epidemiol Biomarkers Prev 30:682\u2013689. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1028","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4967_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132377","author":"T Tabernacki","year":"2024","unstructured":"Tabernacki T, Wang L, Kaelber DC, Xu R, Berger NA (2024) Non-insulin antidiabetic agents and lung cancer risk in drug-naive patients with type 2 diabetes mellitus: a nationwide retrospective cohort study. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16132377","journal-title":"Cancers (Basel)"},{"key":"4967_CR41","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1182\/blood.2019003977","volume":"137","author":"DL Tao","year":"2021","unstructured":"Tao DL, Tassi Yunga S, Williams CD, McCarty OJT (2021) Aspirin and antiplatelet treatments in cancer. Blood 137:3201\u20133211. https:\/\/doi.org\/10.1182\/blood.2019003977","journal-title":"Blood"},{"key":"4967_CR42","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.121.318051","volume":"128","author":"DCH van Dorst","year":"2021","unstructured":"van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN (2021) Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circ Res 128:1040\u20131061. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318051","journal-title":"Circ Res"},{"key":"4967_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"4967_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-022-00632-z","volume":"23","author":"Q Wang","year":"2022","unstructured":"Wang Q, Liu Z, Tang S, Wu Z (2022) Morphine suppresses the immune function of lung cancer by up-regulating MAEL expression. BMC Pharmacol Toxicol 23:92. https:\/\/doi.org\/10.1186\/s40360-022-00632-z","journal-title":"BMC Pharmacol Toxicol"},{"key":"4967_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12916-023-03086-0","volume":"21","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shi Q, Wang Z, Lu J, Hou J (2023a) Integrating plasma proteomes with genome-wide association data for causal protein identification in multiple myeloma. BMC Med 21:377. https:\/\/doi.org\/10.1186\/s12916-023-03086-0","journal-title":"BMC Med"},{"key":"4967_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12890-023-02588-0","volume":"23","author":"X Wang","year":"2023","unstructured":"Wang X, Liu X, Li Y, Tang M, Meng X, Chai Y, Zhang L, Zhang H (2023b) The causal relationship between thyroid function, autoimune thyroid dysfunction and lung cancer: a Mendelian randomization study. BMC Pulm Med 23:338. https:\/\/doi.org\/10.1186\/s12890-023-02588-0","journal-title":"BMC Pulm Med"},{"key":"4967_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667097","volume":"12","author":"K Xiang","year":"2021","unstructured":"Xiang K, Wang P, Xu Z, Hu YQ, He YS, Chen Y, Feng YT, Yin KJ, Huang JX, Wang J, Wu ZD, Yang XK, Wang DG, Ye DQ, Pan HF (2021) Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample Mendelian randomization study. Front Immunol 12:667097. https:\/\/doi.org\/10.3389\/fimmu.2021.667097","journal-title":"Front Immunol"},{"key":"4967_CR48","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","volume":"131","author":"XR Xu","year":"2018","unstructured":"Xu XR, Yousef GM, Ni H (2018) Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents. Blood 131:1777\u20131789. https:\/\/doi.org\/10.1182\/blood-2017-05-743187","journal-title":"Blood"},{"key":"4967_CR49","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00432-024-05960-7","volume":"150","author":"F Yang","year":"2024","unstructured":"Yang F, Li O, Gao B, Chen Z, Li B, He J, Yang X (2024) Association between antithrombotic agents use and hepatocellular carcinoma risk: a two-sample Mendelian randomization analysis. J Cancer Res Clin Oncol 150:470. https:\/\/doi.org\/10.1007\/s00432-024-05960-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"4967_CR50","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.04057","volume":"14","author":"Z Yun","year":"2024","unstructured":"Yun Z, Shen Y, Yan X, Tian S, Wang J, Teo CS, Zhao H, Xue C, Dong Q, Hou L (2024) Association between 19 medication use and risk of common cancers: a cross-sectional and Mendelian randomisation study. J Glob Health 14:04057. https:\/\/doi.org\/10.7189\/jogh.14.04057","journal-title":"J Glob Health"},{"key":"4967_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.therap.2023.11.003","volume":"79","author":"Y Zelmat","year":"2024","unstructured":"Zelmat Y, Despas F (2024) Drug-induced tumoral disease: a global pharmacovigilance database analysis. Therapie 79:189\u2013197. https:\/\/doi.org\/10.1016\/j.therap.2023.11.003","journal-title":"Therapie"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04967-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:58:07Z","timestamp":1782097087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4967"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04967-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All GWAS summary data in this study are publicly available, exempting the need for additional ethical approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}